Brief: Mithra Pharmaceuticals To Commercialise Estelle In South Korea With Hyundai Pharm
05/06/2018 06:39
June 5 (Reuters) - MITHRA PHARMACEUTICALS SA MITRA.BR :
* MITHRA SIGNS BINDING HEADS OF TERMS FOR COMMERCIALIZATION
OF
ESTELLE IN SOUTH KOREA WITH WOMEN'S HEALTH SPECIALIST HYUNDAI
PHARM 004310.KS
* ELIGIBLE FOR MILESTONE PAYMENTS, RECURRING REVENUES AND
FURTHER
SALES-RELATED ROYALTY PAYMENTS
* WILL PRODUCE ESTELLE FOR THE SOUTH KOREAN MARKET AT ITS
CDMO.
Source text for Eikon: ID:nNDL6PHBsh
Further company coverage: MITRA.BR
(Gdynia Newsroom:)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Hyundai Pharmaceutical
See all newsS.Korea morning-after pill makers jump as court strikes down abortion law
S.Korean stocks close little changed; won edges lower
Brief: Acerus Pharmaceuticals Announces Approval Of Natesto In South Korea
Brief: Mithra Pharmaceuticals To Commercialise Estelle In South Korea With Hyundai Pharm
Brief: Hyundai Pharmaceutical to pay annual cash dividend as 50 won/share